Seagen Inc. financial data

Industry
Biological Products, (No Diagnostic Substances)
Location
21823 30 Th Drive Se, Suite, Bothell, WA
State of incorporation
Washington
Fiscal year end
December 31
Former names
SEATTLE GENETICS INC /WA (to 10/8/2020)
Latest financial report
10-Q - Q3 2023 - Nov 1, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 322 % -29.8%
Quick Ratio 59.2 % +24.1%
Return On Equity -28.1 % -30.2%
Return On Assets -20.9 % -19.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 189M shares +1.62%
Common Stock, Shares, Outstanding 189M shares +1.83%
Common Stock, Value, Issued 189K USD +2.16%
Weighted Average Number of Shares Outstanding, Basic 188M shares +1.81%
Weighted Average Number of Shares Outstanding, Diluted 188M shares +1.81%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 2.3B USD +23.4%
Research and Development Expense 1.56B USD +21.1%
Costs and Expenses 3.09B USD +23.9%
Operating Income (Loss) -791M USD -25.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -739M USD -16.3%
Income Tax Expense (Benefit) 11.3M USD +766%
Net Income (Loss) Attributable to Parent -750M USD -17.8%
Earnings Per Share, Basic -4.01 USD/shares -16.2%
Earnings Per Share, Diluted -4.01 USD/shares -16.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 429M USD +18.2%
Accounts Receivable, after Allowance for Credit Loss, Current 632M USD +29.7%
Inventory, Net 531M USD +45.5%
Assets, Current 2.55B USD -7.54%
Property, Plant and Equipment, Net 359M USD +55.8%
Operating Lease, Right-of-Use Asset 129M USD +161%
Intangible Assets, Net (Excluding Goodwill) 220M USD -9.48%
Goodwill 275M USD 0%
Other Assets, Noncurrent 100M USD +61.8%
Assets 3.63B USD +0.42%
Accounts Payable, Current 225M USD +55.6%
Employee-related Liabilities, Current 212M USD +58.7%
Accrued Liabilities, Current 730M USD +25.5%
Liabilities, Current 955M USD +31.5%
Operating Lease, Liability, Noncurrent 113M USD +143%
Other Liabilities, Noncurrent 15.6M USD -36.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax 4.39M USD +46.7%
Retained Earnings (Accumulated Deficit) -2.76B USD -37.4%
Stockholders' Equity Attributable to Parent 2.55B USD -9.62%
Liabilities and Equity 3.63B USD +0.42%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -250M USD -15.1%
Net Cash Provided by (Used in) Financing Activities 29.9M USD +12.3%
Net Cash Provided by (Used in) Investing Activities 232M USD +771%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 189M shares +1.83%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 13.6M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 429M USD +16.5%
Operating Lease, Liability 125M USD +106%
Depreciation 12.4M USD +8.96%
Payments to Acquire Property, Plant, and Equipment 38.7M USD +122%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -749M USD -18%
Operating Lease, Liability, Current 11.1M USD -20%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure +40%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Operating Lease, Payments 18.6M USD +6.84%
Amortization of Intangible Assets 23.1M USD -0.01%
Share-based Payment Arrangement, Expense 131M USD +123%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%